Search Results for: cutaneous amyloidosis

1 2 3 13
A Clinical Atlas of 101 Common Skin Diseases

Amyloidosis

  • at006g01.jpg
  • at006g02.jpg
  • at006g03.jpg
  • at006g04.jpg
  • at006g05a.jpg
  • at006g05b.jpg
  • at006g06.jpg
  • at006g07.jpg
  • at006g08.jpg
  • at006g09.jpg

A condition in which deposits of a fibrillary protein (amyloid) appear in the skin as macules, papules, and nodules consequent to the effects of local factors, or as patches (which may be purpuric), plaques, nodules, and tumors as a result of a systemic disease like myeloma.

A Clinical Atlas of 101 Common Skin Diseases

Amyloidosis

A condition in which deposits of a fibrillary protein (amyloid) appear in the skin as macules, papules, and nodules consequent to the effects of local factors, or as patches (which may be purpuric), plaques, nodules, and tumors as a result of a…

Therapeutic Strategies in Dermatology

Tuberculosis, Cutaneous

A condition in which deposits of a fibrillary protein (amyloid) appear in the skin as macules, papules, and nodules consequent to the effects of local factors, or as patches (which may be purpuric), plaques, nodules, and tumors as a result of a…

Therapeutic Strategies in Dermatology

Cutaneous T-Cell Lymphoma/ Mycosis Fungoides

A condition in which deposits of a fibrillary protein (amyloid) appear in the skin as macules, papules, and nodules consequent to the effects of local factors, or as patches (which may be purpuric), plaques, nodules, and tumors as a result of a…

Therapeutic Strategies in Dermatology

Lupus: Key Points

Key Points Lupus is a disease that presents across a broad spectrum of cutaneous and systemic manifestations. It may be cutaneous-only or systemic with cutaneous manifestations; some patients with systemic lupus do not have cutaneous involvement….

Therapeutic Strategies in Dermatology

Sarcoidosis: Key Points

…osuppressive drug, but emerging evidence suggests that TNF-α inhibitors may be particularly effective at treating refractory cutaneous sarcoidosis. Patients with chronic cutaneous sarcoidosis, particularly those with lupus pernio, may fail to…

Therapeutic Strategies in Dermatology

Urticaria Pigmentosa / Mastocytosis: Key Points

…stemic involvement; this chapter will focus specifically on urticaria pigmentosa (UP), with a brief review of other forms of cutaneous mastocytosis. The three most common types of cutaneous mastocytosis are urticaria pigmentosa (UP), diffuse…

Therapeutic Strategies in Dermatology

Kaposi’s Sarcoma: Overview

…ne the extent and rate of progression of the HIV-associated KS. The following staging system may be used: Stage I: Localized cutaneous (fewer than 10 lesions, or one anatomic region); Stage II: Disseminated cutaneous (more than 10 lesions, or more…

Therapeutic Strategies in Dermatology

Cutaneous T-Cell Lymphoma/ Mycosis Fungoides: Overview

…therapy. Refer patients to the most appropriate multidisciplinary team earlier rather than later to insure the best possible cutaneous response. Side effects are those of the agents employed, and patients must be carefully monitored for therapeutic…

Therapeutic Strategies in Dermatology

Leishmaniasis: Overview

…ble for your patient, since the CDC must release the medication (see CDC website). First Steps Treat patients with extensive cutaneous lesions or cutaneous lesions acquired in an area endemic for L. braziliensis with systemic antimonials (i.e.,…

Therapeutic Strategies in Dermatology

Private: Cutaneous Allergic (Leukocytoclastic) Vasculitis: Overview

…required for systemic disease even when skin lesions are mild. First Steps The therapeutic goal is suppression or control of cutaneous lesions and symptoms. Because cutaneous LCV is a self-limited and benign disorder in most cases, one should be…

1 2 3 13